|
related topics |
{product, candidate, development} |
{property, intellectual, protect} |
{product, market, service} |
{customer, product, revenue} |
{personnel, key, retain} |
{system, service, information} |
{cost, regulation, environmental} |
{control, financial, internal} |
{regulation, government, change} |
{financial, litigation, operation} |
{capital, credit, financial} |
{acquisition, growth, future} |
{gas, price, oil} |
|
Our success is dependent on our principal technologies
Products using our technology may not be accepted by the market
Our technology development is in its early stages and the outcome is uncertain
Our development partners have certain rights to jointly developed property and to license our technology
We have limited resources and our focus on particular products may result in our failure to capitalize on other opportunities
We may not be able to provide system integration
Rapid technological changes could render our technology obsolete; and we may not remain competitive
We have limited manufacturing capacity and experience
The health effects of nanotechnology are unknown
The loss of key personnel could adversely affect our business
We have a history of net losses
We have no current royalty agreements producing significant revenue
We are dependent on the availability of materials and suppliers
Our revenues have been dependent on government contracts in the past
We are exposed to litigation liability
We may have future capital needs and the source of that funding is uncertain
We may be unable to enforce or defend our ownership and use of proprietary technology
We have technologies subject to licenses
Full 10-K form ▸
|
|
related documents |
891417--3/2/2006--NANO_PROPRIETARY__INC |
880432--9/28/2010--MISONIX_INC |
64978--2/28/2007--MERCK_&_CO_INC |
64978--2/27/2009--MERCK_&_CO_INC |
32878--9/13/2006--ENERGY_CONVERSION_DEVICES_INC |
849636--3/16/2006--CORTEX_PHARMACEUTICALS_INC/DE/ |
897075--3/17/2008--REPROS_THERAPEUTICS_INC. |
1110803--2/26/2010--ILLUMINA_INC |
880432--9/26/2008--MISONIX_INC |
886530--3/17/2008--DATATRAK_INTERNATIONAL_INC |
351012--8/11/2006--INTERMAGNETICS_GENERAL_CORP |
32878--8/29/2007--ENERGY_CONVERSION_DEVICES_INC |
1026650--3/10/2006--ERESEARCHTECHNOLOGY_INC_/DE/ |
886530--3/16/2009--DATATRAK_INTERNATIONAL_INC |
64978--2/28/2008--MERCK_&_CO_INC |
891288--3/30/2006--QUESTCOR_PHARMACEUTICALS_INC |
878828--3/31/2009--WIRELESS_TELECOM_GROUP_INC |
878828--4/15/2010--WIRELESS_TELECOM_GROUP_INC |
881890--6/14/2010--ABAXIS_INC |
1034682--9/29/2008--HERITAGE_WORLDWIDE_INC |
927761--4/9/2008--MYMETICS_CORP |
1001193--3/17/2008--TRANSMETA_CORP |
897075--3/16/2009--REPROS_THERAPEUTICS_INC. |
875045--2/21/2007--BIOGEN_IDEC_INC |
1102934--11/27/2007--CABOT_MICROELECTRONICS_CORP |
28626--9/13/2007--LIFECORE_BIOMEDICAL_INC |
5768--6/13/2008--AMERICAN_SCIENCE_&_ENGINEERING_INC |
5768--6/15/2009--AMERICAN_SCIENCE_&_ENGINEERING_INC |
880432--9/28/2009--MISONIX_INC |
1040896--4/2/2007--INTELLI_CHECK_INC |
|